Is (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide Safe in Breastfeeding

Question

I am a breastfeeding mother and i want to know if it is safe to use (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide? Is (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide safe for nursing mother and child? Does (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide extracts into breast milk? Does (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide has any long term or short term side effects on infants? Can (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide influence milk supply or can (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide decrease milk supply in lactating mothers?

Answer by DrLact: About (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide usage in lactation

No information is available on the clinical use of (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide during breastfeeding. Because (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide is about 95% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 37 hours and it might accumulate in the infant. the manufacturer recommends that breastfeeding be discontinued during (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide therapy and for 2 weeks after the last dose.

Alternate Drugs

Irinotecan

Vincristine(Dangerous)

Letrozole(Dangerous)

Tamoxifen(Dangerous)

Erlotinib(Unsafe)

Emicizumab

Daratumumab

Ado-Trastuzumab Emtansine

Exemestane(Dangerous)

Idelalisib

Obinutuzumab

Mitoxantrone(Dangerous)

Dinutuximab

Midostaurin

Trastuzumab(Unsafe)

Cladribine(Dangerous)

Inotuzumab Ozogamicin

Mercaptopurine(Safe)

Nivolumab(Unsafe)

Ipilimumab(Unsafe)

Hydroxyurea(Low Risk)

Vinblastine(Dangerous)

Cetuximab(Unsafe)

Etoposide(Dangerous)

Gefitinib

Acalabrutinib

Bleomycin(Dangerous)

Avelumab

Carboplatin(Dangerous)

Moxetumomab Pasudotox

Doxorubicin(Dangerous)

Vinorelbine(Dangerous)

Imatinib(Unsafe)

Paclitaxel(Dangerous)

Topotecan

Crizotinib

Cyclophosphamide(Dangerous)

Dacarbazine(Dangerous)

Fluorouracil(Dangerous)

Cisplatin(Unsafe)

Azelaic Acid(Safe)

Dasatinib(Unsafe)

Alemtuzumab(Low Risk)

Dactinomycin(Dangerous)

Busulfan(Dangerous)

Docetaxel(Dangerous)

Rituximab(Low Risk)

Bevacizumab(Low Risk)

Copanlisib

Thioguanine(Dangerous)

Nintedanib

Gemcitabine(Dangerous)

Pazopanib(Unsafe)

Nilotinib(Unsafe)

Erlotinib(Unsafe)

Imatinib(Unsafe)

Dasatinib(Unsafe)

Orlistat(Low Risk)

Gemcitabine(Dangerous)

Pazopanib(Unsafe)

Nilotinib(Unsafe)

Allopurinol(Safe)

Imatinib(Unsafe)

Dasatinib(Unsafe)

Pazopanib(Unsafe)

Nilotinib(Unsafe)

Erlotinib(Unsafe)

Imatinib(Unsafe)

Dasatinib(Unsafe)

Pazopanib(Unsafe)

Nilotinib(Unsafe)

Erlotinib(Unsafe)

Imatinib(Unsafe)

Dasatinib(Unsafe)

Pazopanib(Unsafe)

Nilotinib(Unsafe)

Erlotinib(Unsafe)

Synonyms of (2E)-N-(4-(3-chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.